ID   RUNX1_RAT               Reviewed;         450 AA.
AC   Q63046;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   29-MAY-2024, entry version 179.
DE   RecName: Full=Runt-related transcription factor 1;
DE   AltName: Full=Acute myeloid leukemia 1 protein;
DE   AltName: Full=Core-binding factor subunit alpha-2;
DE            Short=CBF-alpha-2;
DE   AltName: Full=Oncogene AML-1;
DE   AltName: Full=Polyomavirus enhancer-binding protein 2 alpha B subunit;
DE            Short=PEA2-alpha B;
DE            Short=PEBP2-alpha B;
GN   Name=Runx1; Synonyms=Aml1, Cbfa2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INDUCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Skeletal muscle;
RX   PubMed=7969143; DOI=10.1128/mcb.14.12.8051-8057.1994;
RA   Zhu X., Yeadon J.E., Burden S.J.;
RT   "AML1 is expressed in skeletal muscle and is regulated by innervation.";
RL   Mol. Cell. Biol. 14:8051-8057(1994).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14 AND SER-21, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: CBF binds to the core site, 5'-PYGPYGGT-3', of a number of
CC       enhancers and promoters, including murine leukemia virus, polyomavirus
CC       enhancer, T-cell receptor enhancers, LCK, IL-3 and GM-CSF promoters.
CC       The alpha subunit binds DNA and appears to have a role in the
CC       development of normal hematopoiesis. Isoform AML-1L interferes with the
CC       transactivation activity of RUNX1. Acts synergistically with ELF4 to
CC       transactivate the IL-3 promoter and with ELF2 to transactivate the BLK
CC       promoter. Inhibits KAT6B-dependent transcriptional activation. Controls
CC       the anergy and suppressive function of regulatory T-cells (Treg) by
CC       associating with FOXP3. Activates the expression of IL2 and IFNG and
CC       down-regulates the expression of TNFRSF18, IL2RA and CTLA4, in
CC       conventional T-cells (By similarity). Positively regulates the
CC       expression of RORC in T-helper 17 cells (By similarity).
CC       {ECO:0000250|UniProtKB:Q01196, ECO:0000250|UniProtKB:Q03347}.
CC   -!- SUBUNIT: Heterodimer with CBFB. RUNX1 binds DNA as a monomer and
CC       through the Runt domain. DNA-binding is increased by
CC       heterodimerization. Interacts with TLE1 and ALYREF/THOC4. Interacts
CC       with ELF1, ELF2 and SPI1. Interacts via its Runt domain with the ELF4
CC       N-terminal region. Interaction with ELF2 isoform 2 (NERF-1a) may act to
CC       repress RUNX1-mediated transactivation. Interacts with KAT6A and KAT6B.
CC       Interacts with SUV39H1, leading to abrogation of transactivating and
CC       DNA-binding properties of RUNX1. Interacts with YAP1 and HIPK2.
CC       Interaction with CDK6 prevents myeloid differentiation, reducing its
CC       transcription transactivation activity. Found in a complex with PRMT5,
CC       RUNX1 and CBFB. Interacts with FOXP3. Interacts with TBX21. Interacts
CC       with DPF2 (By similarity). {ECO:0000250|UniProtKB:Q01196,
CC       ECO:0000250|UniProtKB:Q03347}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Expressed in skeletal muscle.
CC       {ECO:0000269|PubMed:7969143}.
CC   -!- INDUCTION: Expression increases following denervation.
CC       {ECO:0000269|PubMed:7969143}.
CC   -!- DOMAIN: A proline/serine/threonine rich region at the C-terminus is
CC       necessary for transcriptional activation of target genes.
CC   -!- PTM: Phosphorylated in its C-terminus upon IL-6 treatment.
CC       Phosphorylation enhances interaction with KAT6A (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Methylated. {ECO:0000250}.
CC   -!- PTM: Phosphorylated in Ser-249 Thr-272 and Ser-275 by HIPK2 when
CC       associated with CBFB and DNA. This phosphorylation promotes subsequent
CC       EP300 phosphorylation (By similarity). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L35271; AAA66191.1; -; mRNA.
DR   RefSeq; NP_059021.1; NM_017325.2.
DR   AlphaFoldDB; Q63046; -.
DR   SMR; Q63046; -.
DR   BioGRID; 248410; 1.
DR   ELM; Q63046; -.
DR   STRING; 10116.ENSRNOP00000070750; -.
DR   GlyGen; Q63046; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q63046; -.
DR   PhosphoSitePlus; Q63046; -.
DR   PaxDb; 10116-ENSRNOP00000002313; -.
DR   Ensembl; ENSRNOT00000002313.5; ENSRNOP00000002313.3; ENSRNOG00000001704.8.
DR   GeneID; 50662; -.
DR   KEGG; rno:50662; -.
DR   UCSC; RGD:2283; rat.
DR   AGR; RGD:2283; -.
DR   CTD; 861; -.
DR   RGD; 2283; Runx1.
DR   eggNOG; KOG3982; Eukaryota.
DR   GeneTree; ENSGT00940000159255; -.
DR   HOGENOM; CLU_032910_0_0_1; -.
DR   InParanoid; Q63046; -.
DR   OrthoDB; 2881451at2759; -.
DR   PhylomeDB; Q63046; -.
DR   Reactome; R-RNO-549127; Organic cation transport.
DR   Reactome; R-RNO-8877330; RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs).
DR   Reactome; R-RNO-8931987; RUNX1 regulates estrogen receptor mediated transcription.
DR   Reactome; R-RNO-8934593; Regulation of RUNX1 Expression and Activity.
DR   Reactome; R-RNO-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-RNO-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-RNO-8939243; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known.
DR   Reactome; R-RNO-8939245; RUNX1 regulates transcription of genes involved in BCR signaling.
DR   Reactome; R-RNO-8939246; RUNX1 regulates transcription of genes involved in differentiation of myeloid cells.
DR   Reactome; R-RNO-8939247; RUNX1 regulates transcription of genes involved in interleukin signaling.
DR   Reactome; R-RNO-9018519; Estrogen-dependent gene expression.
DR   PRO; PR:Q63046; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000001704; Expressed in thymus and 18 other cell types or tissues.
DR   ExpressionAtlas; Q63046; baseline and differential.
DR   GO; GO:0005604; C:basement membrane; ISO:RGD.
DR   GO; GO:0000785; C:chromatin; IDA:RGD.
DR   GO; GO:0016513; C:core-binding factor complex; TAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; IDA:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0001222; F:transcription corepressor binding; ISO:RGD.
DR   GO; GO:0048266; P:behavioral response to pain; ISO:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; ISO:RGD.
DR   GO; GO:0007417; P:central nervous system development; ISO:RGD.
DR   GO; GO:0002062; P:chondrocyte differentiation; IBA:GO_Central.
DR   GO; GO:0060216; P:definitive hemopoiesis; ISO:RGD.
DR   GO; GO:0035162; P:embryonic hemopoiesis; ISO:RGD.
DR   GO; GO:0031069; P:hair follicle morphogenesis; ISO:RGD.
DR   GO; GO:0030097; P:hemopoiesis; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0001889; P:liver development; ISO:RGD.
DR   GO; GO:0030099; P:myeloid cell differentiation; ISO:RGD.
DR   GO; GO:0002573; P:myeloid leukocyte differentiation; ISO:RGD.
DR   GO; GO:0002318; P:myeloid progenitor cell differentiation; ISO:RGD.
DR   GO; GO:0043371; P:negative regulation of CD4-positive, alpha-beta T cell differentiation; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0048666; P:neuron development; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; ISO:RGD.
DR   GO; GO:0048663; P:neuron fate commitment; ISO:RGD.
DR   GO; GO:0001503; P:ossification; IBA:GO_Central.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB.
DR   GO; GO:0043378; P:positive regulation of CD8-positive, alpha-beta T cell differentiation; ISS:UniProtKB.
DR   GO; GO:1903431; P:positive regulation of cell maturation; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IMP:RGD.
DR   GO; GO:0030854; P:positive regulation of granulocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0032743; P:positive regulation of interleukin-2 production; ISO:RGD.
DR   GO; GO:2000872; P:positive regulation of progesterone secretion; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0032729; P:positive regulation of type II interferon production; ISO:RGD.
DR   GO; GO:0045595; P:regulation of cell differentiation; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0071336; P:regulation of hair follicle cell proliferation; ISO:RGD.
DR   GO; GO:0009966; P:regulation of signal transduction; ISO:RGD.
DR   GO; GO:0002667; P:regulation of T cell anergy; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0014894; P:response to denervation involved in regulation of muscle adaptation; IEP:RGD.
DR   GO; GO:0032526; P:response to retinoic acid; ISO:RGD.
DR   GO; GO:0001501; P:skeletal system development; ISO:RGD.
DR   Gene3D; 2.60.40.720; -; 1.
DR   InterPro; IPR000040; AML1_Runt.
DR   InterPro; IPR008967; p53-like_TF_DNA-bd_sf.
DR   InterPro; IPR012346; p53/RUNT-type_TF_DNA-bd_sf.
DR   InterPro; IPR013524; Runt_dom.
DR   InterPro; IPR027384; Runx_central_dom_sf.
DR   InterPro; IPR013711; RunxI_C_dom.
DR   InterPro; IPR016554; TF_Runt-rel_RUNX.
DR   PANTHER; PTHR11950; RUNT RELATED; 1.
DR   PANTHER; PTHR11950:SF40; RUNT-RELATED TRANSCRIPTION FACTOR 1; 1.
DR   Pfam; PF00853; Runt; 1.
DR   Pfam; PF08504; RunxI; 1.
DR   PIRSF; PIRSF009374; TF_Runt-rel_RUNX; 1.
DR   PRINTS; PR00967; ONCOGENEAML1.
DR   SUPFAM; SSF49417; p53-like transcription factors; 1.
DR   PROSITE; PS51062; RUNT; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; DNA-binding; Methylation; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; Transcription; Transcription regulation.
FT   CHAIN           1..450
FT                   /note="Runt-related transcription factor 1"
FT                   /id="PRO_0000174657"
FT   DOMAIN          50..178
FT                   /note="Runt"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00399"
FT   REGION          1..25
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          80..84
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   REGION          135..143
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   REGION          168..177
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   REGION          170..195
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          209..252
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          290..369
FT                   /note="Interaction with KAT6A"
FT                   /evidence="ECO:0000250"
FT   REGION          306..398
FT                   /note="Interaction with KAT6B"
FT                   /evidence="ECO:0000250"
FT   REGION          360..400
FT                   /note="Interaction with FOXP3"
FT                   /evidence="ECO:0000250|UniProtKB:Q01196"
FT   REGION          410..450
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        170..186
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        222..252
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        410..438
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         112
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00399"
FT   BINDING         116
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00399"
FT   BINDING         139
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00399"
FT   BINDING         170
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00399"
FT   MOD_RES         14
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         21
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01196"
FT   MOD_RES         43
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01196"
FT   MOD_RES         193
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01196"
FT   MOD_RES         212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01196"
FT   MOD_RES         249
FT                   /note="Phosphoserine; by HIPK2"
FT                   /evidence="ECO:0000250|UniProtKB:Q01196"
FT   MOD_RES         266
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01196"
FT   MOD_RES         267
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01196"
FT   MOD_RES         272
FT                   /note="Phosphothreonine; by HIPK2"
FT                   /evidence="ECO:0000250|UniProtKB:Q01196"
FT   MOD_RES         275
FT                   /note="Phosphoserine; by HIPK2"
FT                   /evidence="ECO:0000250|UniProtKB:Q01196"
FT   MOD_RES         295
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01196"
FT   MOD_RES         433
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01196"
SQ   SEQUENCE   450 AA;  48556 MW;  4B53AD706D487AC3 CRC64;
     MRIPVDASTS RRFTPPSTAL SPGKMSEALP LGAPDGGAAL ASKLRSGDRS MVEVLADHPG
     ELVRTDSPNF LCSVLPTHWR CNKTLPIAFK VVALGDVPDG TLVTVMAGND ENYSAELRNA
     TAAMKNQVAR FNDLRFVGRS GRGKSFTLTI TVFTNPPQVA TYHRAIKITV DGPREPRRHR
     QKLDDQTKPG SLSFSERLSE LEQLRRTAMR VSPHHPAPTP NPRASLNHST AFNPQPQSQM
     QDARQIQPSP PWSYDQSYQY LGSITSSVHP ATPISPGRAS GMTSLSAELS SRLSTAPDLT
     AFGDPRQFPT LPSISDPRMH YPGAFTYSPP VTSGIGIGMS AMSSTSRYHT YLPPPYPGSS
     QAQAGPFQTG SPSYHLYYGT SAGSYQFSMV GGERSPPRIL PPCTNASTGA ALLNPSLPSQ
     SDVVETEGSH SNSPTNMPPA RLEEAVWRPY
//
